Natural Products and LncRNAs in Non‐Small Cell Lung Cancer: Emerging Therapeutic Approaches
The Journal of Gene Medicine · 2025
DOI: 10.1002/jgm.70054 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Gene Medicine, 2025. Verfasst von Ahmed S Doghish und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Egypt. Hauptthemen laut MEDLINE: Biological Products, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 155 Literaturangaben.
Abstract (Originalsprache)
Non‐small cell lung cancer (NSCLC) is considered a major contributor to cancer‐related death rates worldwide, chiefly owing to late diagnosis, occurrence of metastasis, and treatment resistance. Growing evidence underscores the impact of long non‐coding RNAs (lncRNAs) on NSCLC progression. These lncRNAs have been demonstrated to influence cell proliferation, apoptosis, epithelial‐mesenchymal transition (EMT), and drug resistance, contributing to cancer development and therapeutic failure. Concurrently, natural products and nutraceuticals are gaining attention for their anticancer properties, particularly in modulating signaling pathways involved in tumorigenesis and drug resistance. Compounds like curcumin, resveratrol, and epigallocatechin gallate have been shown to regulate oncogenic lncRNAs, inhibiting metastasis and reversing chemoresistance. Additionally, natural products upregulate tumor‐suppressive lncRNAs, restoring cell cycle control and apoptosis. This review provides an in‐depth analysis of the etiological significance of lncRNAs in NSCLC, with a particular emphasis on their contribution to tumorigenesis, metastasis, and therapeutic resistance. In addition, it explores the potential of natural products to modulate lncRNA expression, highlighting their efficacy in overcoming drug resistance and enhancing the therapeutic response. By elucidating the dynamic molecular cross‐talk between lncRNAs and natural products, this review also aims to identify novel therapeutic strategies and potential biomarkers for the diagnosis and treatment of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Egypt.
- Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.
- Department of Pharmacy, Kut University College, Al Kut, Iraq.
- Department of Biochemistry, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt.
ORCID-Profile: Ahmed S Doghish, Hanan Elimam
Zitieren
APA
Doghish, A. S., Abd-Elmawla, M. A., Ghaiad, H. R., Aborehab, N. M., Radwan, A. F., Nassar, K., Mohammed, O. A., & Elimam, H. (2025). Natural Products and LncRNAs in Non‐Small Cell Lung Cancer: Emerging Therapeutic Approaches. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70054
Vancouver
Doghish AS, Abd-Elmawla MA, Ghaiad HR, Aborehab NM, Radwan AF, Nassar K, et al. Natural Products and LncRNAs in Non‐Small Cell Lung Cancer: Emerging Therapeutic Approaches. The Journal of Gene Medicine. 2025. doi:10.1002/jgm.70054
BibTeX
@article{Doghish2025,
author = {Doghish, Ahmed S and Abd-Elmawla, Mai A and Ghaiad, Heba R and Aborehab, Nora M and Radwan, Abdullah F and Nassar, Khloud and Mohammed, Osama A and Elimam, Hanan},
title = {Natural Products and LncRNAs in Non‐Small Cell Lung Cancer: Emerging Therapeutic Approaches},
journal = {The Journal of Gene Medicine},
year = {2025},
doi = {10.1002/jgm.70054}
}
EUVIMED